Federal Register / Vol. 74, No. 185 / Friday, September 25, 2009 / Notices 48981 

the key issues from on-site session 

attendees. As time allows, telephone 

participants will also have the 

opportunity to provide brief 2-minute 

comments. The meeting will conclude 

by 1 p.m. e.s.t. with brief comments on 

next steps. 

III. Registration Instructions 

For security reasons, any persons 

wishing to attend this meeting must 

register by the date listed in the DATES

section of this notice. Persons interested 

in attending the meeting or participating 

by teleconference must register by 

completing the on-line registration via 

the Web site at http:// 

www2.eventsvc.com/stage/palmettogba/ 

111009. The on-line registration system 

will generate a confirmation page to 

indicate the completion of your 

registration. Please print this page as 

your registration receipt. 

Individuals may also participate in 

the listening session by teleconference. 

Registration is required as the number of 

call-in lines will be limited. The call-in 

number will be provided upon 

confirmation of registration. 

An audio download of the listening 

session will be available through the 

CMS Resource Use Web site within 72 

hours after completion of the listening 

session. Use Web site at http:// 

www.cms.hhs.gov/center/physician.asp. 

IV. Security, Building, and Parking 

Guidelines 

This meeting will be held in a Federal 

government building; therefore, Federal 

security measures are applicable. In 

planning your arrival time, we 

recommend you to arrive to the central 

building by 8 a.m so that you will have 

enough time to check-in before the 

session begins. The on-site check-in for 

visitors will begin at 8:15 a.m. e.s.t. 

Security measures will include 

inspection of vehicles, inside and out, at 

the entrance to the grounds. In addition, 

all persons entering the building must 

check in by name with Security, provide 

a government-issued ID, and pass 

through a metal detector. All items 

brought to the building, whether 

personal or for the purpose of 

demonstration or to support a 

presentation, including items such as 

laptops, cell phones, and palm pilots, 

are subject to physical inspection. 

Authority: Section 131(d) The Medicare 

Improvements for Patients and Providers Act 

of 2008. 

Dated: September 17, 2009. 

Charlene Frizzera, 

Acting Administrator, Centers for Medicare 

& Medicaid Services. 

[FR Doc. E9–22959 Filed 9–24–09; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–7015–N] 

Medicare Program; Meeting of the 

Advisory Panel on Medicare 

Education, October 20, 2009 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice of meeting. 

SUMMARY: This notice announces a 

meeting of the Advisory Panel on 

Medicare Education (the Panel) in 

accordance with the Federal Advisory 

Committee Act. The Panel advises and 

makes recommendations to the 

Secretary of Health and Human Services 

and the Administrator of the Centers for 

Medicare & Medicaid Services on 

opportunities to enhance the 

effectiveness of consumer education 

strategies concerning the Medicare 

program. This meeting is open to the 

public. 

DATES: Meeting Date: October 20, 2009 

from 8:30 a.m. to 3 p.m., eastern 

daylight time (e.d.t.). 

Deadline for Meeting Registration, 

Presentations and Comments: October 

13, 2009, 5 p.m., e.d.t. 

Deadline for Requesting Special 

Accommodations: October 6, 2009, 5 

p.m., e.d.t. 

ADDRESSES: Meeting Location: Hilton 

Washington Hotel Embassy Row, 2015 

Massachusetts Avenue, NW., 

Washington, DC 20036, (202) 265–6800. 

Meeting Registration, Presentations, 

and Written Comments: Lynne Johnson, 

Designated Federal Official, Division of 

Forum and Conference Development, 

Office of External Affairs, Centers for 

Medicare & Medicaid Services, 7500 

Security Boulevard, Mailstop S1–05–06, 

Baltimore, MD 21244–1850 or contact 

Ms. Johnson via e-mail at 

Lynne.Johnson@cms.hhs.gov. 

Registration: The meeting is open to 

the public, but attendance is limited to 

the space available. Persons wishing to 

attend this meeting must register by 

contacting Lynne Johnson at the address 

listed in the ADDRESSES section of this 

notice or by telephone at (410) 786– 

0090, by the date listed in the DATES

section of this notice. 

FOR FURTHER INFORMATION CONTACT: 

Lynne Johnson, (410) 786–0090. Please 

refer to the CMS Advisory Committees’ 

Information Line (1–877–449–5659 toll 

free)/(410–786–9379 local) or the 

Internet (http://www.cms.hhs.gov/ 

FACA/04_APME.asp) for additional 

information and updates on committee 

activities. Press inquiries are handled 

through the CMS Press Office at (202) 

690–6145. 

SUPPLEMENTARY INFORMATION: Section 

9(a)(2) of the Federal Advisory 

Committee Act authorizes the Secretary 

of Health and Human Services (the 

Secretary) to establish an advisory panel 

if the Secretary determines that the 

panel is ‘‘in the public interest in 

connection with the performance of 

duties imposed * * * by law.’’ Such 

duties are imposed by section 1804 of 

the Social Security Act (the Act), 

requiring the Secretary to provide 

informational materials to Medicare 

beneficiaries about the Medicare 

program, and section 1851(d) of the Act, 

requiring the Secretary to provide for 

‘‘activities * * * to broadly disseminate 

information to [M]edicare beneficiaries 

* * * on the coverage options provided 

under [Medicare Advantage] in order to 

promote an active, informed selection 

among such options.’’ 

The Panel is also authorized by 

section 1114(f) of the Act (42 U.S.C. 

1311(f)) and section 222 of the Public 

Health Service Act (42 U.S.C. 217a). The 

Secretary signed the charter establishing 

this Panel on January 21, 1999 (64 FR 

7899, February 17, 1999) and approved 

the renewal of the charter on January 21, 

2009 (74 FR 13442, March 27, 2009). 

The Panel advises and makes 

recommendations to the Secretary and 

the Administrator of the Centers for 

Medicare & Medicaid Services (CMS) on 

opportunities to enhance the 

effectiveness of consumer education 

strategies concerning the Medicare 

program. 

The goals of the Panel are as follows: 

• To provide recommendations on 

the development and implementation of 

a national Medicare education program 

that describes benefit options under 

Medicare. 

• To enhance the Federal 

government’s effectiveness in informing 

the Medicare consumer. 

• To make recommendations on how 

to expand outreach to vulnerable and 

underserved communities, including 

racial and ethnic minorities, in the 

context of a national Medicare 

education program. 

• To assemble an information base of 

best practices for helping consumers 

evaluate benefit options and build a 


jlentini on DSKJ8SOYB1PROD with NOTICES
48982 Federal Register / Vol. 74, No. 185 / Friday, September 25, 2009 / Notices 

community infrastructure for 

information, counseling, and assistance. 

The current members of the Panel are: 

Gwendolyn T. Bronson, SHINE/SHIP 

Counselor, Massachusetts SHINE 

Program; Dr. Yanira Cruz, President and 

Chief Executive Officer, National 

Hispanic Council on Aging; Stephen L. 

Fera, Vice President, Social Mission 

Programs, Independence Blue Cross; 

Nan Kirsten-Forte ́, Executive Vice 

President, Consumer Services, WebMD; 

Cathy Graeff, R.Ph., M.B.A., National, 

Senior Vice President, Communications 

and Industry Relations, National 

Council for Prescription Drug Programs; 

Dr. Carmen R. Green, Director, Pain 

Research Division, Associate Professor, 

Anesthesiology, University of Michigan 

Health System; Dr. Jessie C. Gruman, 

President and Chief Executive Officer, 

Center for the Advancement of Health; 

Cindy Hounsell, J.D., President, 

Women’s Institute for a Secure 

Retirement; Kathy Hughes, Vice 

Chairwoman, Oneida Nation; Gail Hunt, 

President and Chief Executive Officer, 

National Alliance for Caregiving; Dr. 

Andrew M. Kramer, Professor of 

Medicine, University of Colorado, 

Denver; Dr. Frank B. McArdle, Manager, 

Hewitt Research Office, Hewitt 

Associates; Sandy Markwood, Chief 

Executive Officer, National Area 

Agencies on Aging; David Roberts, 

M.P.A., Vice President, Government 

Relations, Healthcare Information and 

Management Systems Society; Julie 

Bode ̈n Schmidt, Associate Vice 

President, Training and Technical 

Assistance Department, National 

Association of Community Health 

Centers; Rebecca Snead, Executive Vice 

President and Chief Executive Officer, 

National Alliance of State Pharmacy 

Associations. 

The agenda for the October 20, 2009 

meeting will include the following: 

• Recap of the previous (July 8, 2009) 

meeting. 

• Subgroup Committee Work 

Summary. 

• Medicare Outreach and Education 

Strategies. 

• Public Comment. 

• Listening Session with CMS 

Leadership. 

• Next Steps. 

Individuals or organizations that wish 

to make a 5-minute oral presentation on 

an agenda topic should submit a written 

copy of the oral presentation to Lynne 

Johnson at the address listed in the 

ADDRESSES section of this notice by the 

date listed in the DATES section of this 

notice. The number of oral presentations 

may be limited by the time available. 

Individuals not wishing to make a 

presentation may submit written 

comments to Ms. Johnson at the address 

listed in the ADDRESSES section of this 

notice by the date listed in the DATES

section of this notice. 

Individuals requiring sign language 

interpretation or other special 

accommodations should contact Ms. 

Johnson at the address listed in the 

ADDRESSES section of this notice by the 

date listed in the DATES section of this 

notice. 

Authority: Sec. 222 of the Public Health 

Service Act (42 U.S.C. 217a) and sec. 10(a) 

of Pub. L. 92–463 (5 U.S.C. App. 2, sec. 10(a) 

and 41 CFR 102–3). 

(Catalog of Federal Domestic Assistance 

Program No. 93.733, Medicare—Hospital 

Insurance Program; and Program No. 93.774, 

Medicare—Supplementary Medical 

Insurance Program) 

Dated: September 18, 2009. 

Charlene Frizzera, 

Acting Administrator, Centers for Medicare 

& Medicaid Services. 

[FR Doc. E9–23122 Filed 9–24–09; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; ZRG1 

DKUS–K 11 Nephrology and Urology Small 

Business Review. 

Date: October 13–14, 2009. 

Time: 9 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Krystyna E. Rys-Sikora, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4112, 

MSC 7814, Bethesda, MD 20892, 301–451– 

1325, ryssokok@csr.nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience; Integrated 

Review Group Cellular and Molecular 

Biology of Neurodegeneration Study Section. 

Date: October 14–15, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Catamaran Resort Hotel, 3999 

Mission Boulevard, San Diego, CA 92109. 

Contact Person: Laurent Taupenot, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4183, 

MSC 7850, Bethesda, MD 20892, 301–435– 

1203, taupenol@csr.nih.gov. 

Name of Committee: Bioengineering 

Sciences & Technologies Integrated Review; 

Group Microscopic Imaging Study Section. 

Date: October 14, 2009. 

Time: 12 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Malgorzata Klosek, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4188, 

MSC 7849, Bethesda, MD 20892, (301) 435– 

2211, klosekm@csr.nih gov. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group; 

Therapeutic Approaches to Genetic Diseases. 

Date: October 15, 2009. 

Time: 8 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Avenue, NW., Washington, DC 20037. 

Contact Person: Michael K. Schmidt, PhD, 

Scientific Review Officer Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 2214, MSC 7890, 

Bethesda, MD 20892, (301) 435–1147, 

mschmidt@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Therapeutic 

Approaches to Genetic Diseases-SEP. 

Date: October 15, 2009. 

Time: 4 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Avenue, NW., Washington, DC 20037. 

Contact Person: Michael K. Schmidt, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2214, 

MSC 7890, Bethesda, MD 20892, (301) 435– 

1147, mschmidt@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Drug 

Discovery for the Nervous System. 

Date: October 16, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Allerton Hotel, 701 North 

Michigan Avenue, Chicago, IL 60611. 

Contact Person: Mary Custer, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4148, 


jlentini on DSKJ8SOYB1PROD with NOTICES